I-Radicava yiyure yokuqala ye-FDA evumelekileyo ye-ALS kwiminyaka engaphezu kwe-20
Iyeza elitsha elithi Radicava (edaravone) lavunywa ngoMeyi 2017 kunyango lwe- amyotrophic lateral sclerosis (ALS) . Yavunyelwe eJapan ngaphambi kokuba ivunyiwe eMelika. Olu luphuhliso oluphawulekayo kuba liyi-ADA yokuqala yesigunyazisiweyo se-ALS kwiminyaka engaphezu kwe-20.
I-ALS yintlupheko yesifo esenza ubuthakathaka beemisipha kwaye ibuhlungu ngokukhawuleza, okubangelwa ukukhubazeka okupheleleyo kwithuba leminyaka embalwa nje.
Iimpawu zokuqala ziquka ubuthathaka obuncinane kunye nokuqhaqhaqhaqhaqhaqa okungabonakalisa iingalo, imilenze, ubuso okanye ulwimi.
I-Radicava yenye yezinto ezimbalwa ezonyango ezifumanekayo ze-ALS, esinye sezizathu zokuba le myeza ibaluleke kakhulu. Ekubeni i-ALS ikhubaza, ukucotha okanye ukuvala isifo kunokunciphisa ukukhubazeka nokunyusa ubomi balabo bahlala nayo.
I-Radicava isebenza njani?
I-Radicava ikholelwa ukuba iyakhusela ukunyuka kwe-ALS ngokusebenza njenge-antioxidant. I-Antioxidants inqanda uhlobo lomonakalo emzimbeni obizwa ngokuba ngumonakalo okhuselweyo. Abantu abano-ALS baye bafunyanwa banobungqina obunobungozi obuninzi ngaphezu kwezinto ezingenazo i-ALS, ezinokuthi ubuncinane zijongene nesifo.
EJapan, ityala leenyanga ezi-6 likaRadicava lubonise ukuba abathathi-nxaxheba be-ALS abathabatha isilwanyana ababenokuphuka kancinci komsebenzi wabo wemihla ngemihla kunabathathi-nxaxheba be-ALS abangazange bathathe uRadicava.
Usebenzisa njani iRadicava?
I-Radicava ithathwa nge-infraction infraction (IV) kwaye kufuneka inikwe ngunyango lwezempilo. Ukuxhamla kuqhubeka malunga neyure kwaye kuthathwa imihla ngemihla ezili-14 ngokulandelelana, kulandelwa ukuphulwa kweentsuku ezili-14. Emva komjikelezo wokuqala wemihla ngemihla engama-28, ukujikelezwa kwamanzi okuphindaphindiweyo kuthathwa ngokuthatha uRadicava iintsuku ezili-10 kwiintsuku eziyi-14 zokuqala zomjikelezo, zilandelwa kwakhona nge-14-day break break.
Iimpembelelo ezingasemva
Iziphumo eziqhelekileyo ezichaphazelekayo zeRadiocava zibandakanya ukunyunyuzwa kunye neengxaki zokuhamba. Nangona kungabonakali kuyimpembelelo yecala eliqhelekileyo, uRadiocava inokubangela ukuba iziphumo ezinjengeengcingo kunye nokuphefumula. Ukufumana iziphumo ezichaphazelekayo xa uthatha isicatshulwa esicinga ukuba luncedo kuyaqondakala.
Ngaphambi kokuba ukhethe le nyango, qi niseka ukuba uxoxe ngengozi yeziphumo zecala kunye nogqirha wakho ukuze aqonde indlela anokuchaphazela ngayo imeko ethile kunye nendlela yokuhlangabezana nayo.
Ezinye iindlela zokonyango
Xa ugqiba ukuba i-Radicava ikwawe, kubalulekile ukuqwalasela ezinye iindlela zokwenza unyango. Ngelishwa, kukho imithi embalwa kakhulu ekhoyo kubantu abahlala ne-ALS.
Amachiza abizwa ngokuba yiRiluzol avunywe ngo-1996. Le nyanga ikholelwa ukuba isebenza ngokunciphisa isenzo semichiza ebizwa ngokuba yi-glutamic acid, eyaziwayo ngaphezu kokuvuselela inkqubo yeentlanzi, ezinokubangela ukuba umonakalo unomphela kwiiswini.
Ezinye iindlela zonyango ze-ALS zijoliswe ekulawuleni iimpawu njengoko ziza, kwaye azikwazi ukucotha okanye ukuyeka isifo. Ngokomzekelo, amayeza enyango kunye nemithi eyanciphisa ukungahambi kakuhle kubangelwa ukuqina kobuthakathaka obungasetyenziswa xa unamava okanye ubunzima be-muscle.
Ngokufanayo, izixhobo zonyango ezinjengeengqungquthela ezixhasayo, izihlalo zabakhubazekile kunye nezibilini zokutya zingakwenza lula ubomi bakho nge-ALS, kodwa ayikwazi ukuguqula okanye ukuyeka isifo ngokwayo.
Ukuphila nge-ALS ephakamileyo kuthetha ukuba abantu bafumana ubuthathaka obupheleleyo beengalo, imilenze, umzimba kunye nobuso, ngelixa bekwazi ukucinga, ukuziva, ukubona, ukuva, nokuhambisa amehlo abo. Kwizigaba eziphambili, abaninzi abakwazi ukuthetha, ukuhlafuna, okanye ukugwinya ukutya ngenxa yobuthathaka bemisipha elawula ubuso kunye nokunyakaza komlomo. Noko ke, unxibelelwano lunokwenzeka xa unayo i-ALS, kuba unokuqonda abanye kwaye ungasebenzisa ubuchule, njengeteknoloji yekhompyutha, ukuthetha.
Ngokuqhelekileyo, i-ALS ibangela ukukhubazeka kakhulu kunye nokufa phakathi neminyaka embalwa yokuqala kwempawu. Unyango oluye ludambisa le nkqubela li thembisa. Ukuxoxa ngezibonelelo zalo kwimeko yakho kunye nogqirha wakho.
ILizwi
Ngokutsho kwamaZiko okuLawulwa kweNtsholongwane kunye nokuKhusela (CDC), malunga ne-12 000 ukuya ku-15 000, ama-America okwangoku ahlala ne-ALS, okwenza kube yinto engaqhelekanga, kodwa kubaluleke kakhulu kunabo bonke abantu abahluphekileyo nge-ALS, kunye bathandekayo kunye nabahlobo.
I-ALS yenye yezona zinto ziyingozi kakhulu kwaye ziphazamisekile. Enye yeengxaki ezinzima kakhulu zokuhlala ne-ALS kukuba ukusebenza kwengqondo kubalondolozwe kakhulu kubantu abaninzi abane-ALS xa kuthelekiswa nokunciphisa umzimba. Ukwazi ukuba kukho iindlela ezimbalwa zokonyango ezitholakalayo ziyakhathaza.
Ukuvunyelwa kukaRadicava unyango lwe-ALS lu thembisa. Ukunyuka kwangoko kwisaziso ngesifo, ubuninzi balo mngeni mngcipheko weqhokheni, kunokubangela ukuba kubekho uphuhliso lwezesayensi olusasazayo. Okwangoku, abo abane-ALS banokuzuza ngokujoyina iqela lokuxhasa okanye bafunde nokuba ngaba bafuna ukuthatha inxaxheba kwonyango lokulinga njengoko uphando luqhubeka kule ndawo.
> Imithombo:
> Nagase M, et al. Ukunyuka kwengcinezelo yeengxaki kwizigulane ezine-amyotrophic lateral sclerosis kunye nomphumo wokulawulwa kwe-edaravone. I-Redox Rep. 2016 Ngamana; 21 (3): 104-12.
> Isebe lezeMpilo laseMzantsi Afrika kunye neNkonzo zoLuntu. I-FDA iyavuma iMichiza yokuphatha ii-ALS. 2017.